iiinova — where your digital self keeps evolving

Amy Beumer @amybeumer.bsky.social · 20/10/2025

Miss Gwen so much. Was just thinking of her yesterday and our chat.

Reposted by Amy Beumer

Project Life @projectlifembc.bsky.social · 14/08/2025

It's that time of the month again! Do you love mail...fun mail?! Sign ups are open TODAY for our September Sunshine & Rainbows. 🌈 RSVP through the link in our bio 💌 #mbc #stage4needsmore #bcsm #busylivingwithmets #bccww

031

Reposted by Amy Beumer

Kelly Shanahan @stage4kelly.bsky.social · 25/03/2025

non-Governmental research funding is becoming more important every day. @metavivor.bsky.social received almost double the usual number of letters of intent last week. We need our supporters to be generous this year so we can fund promising research!

0177

Amy Beumer @amybeumer.bsky.social · 03/02/2025

Very concerned. And with the removal of information on health disparities and anything on health of the LGBTQ community.

183

Reposted by Amy Beumer

Advocates for Collaborative Education @advocatecollab.bsky.social · 14/01/2025

REMINDER: ACE Meeting on cancer vaccines today 1pmPT / 4pmET. Join us to hear from advocate & ACE member Judy Fitzgerald as she shares her experience as an advocate on current vaccine trials. As always presentation will be short so bulk of the time can be spent on Q&A / discussion #OncoSky #Advocacy

052

Amy Beumer @amybeumer.bsky.social · 09/01/2025

Tumor board Tuesday!! HR+ MBC! Looking forward to it @dr-rshatsky.bsky.social! #bcsm

150

Reposted by Amy Beumer

Rod Ritchie @malefitness.bsky.social · 28/12/2024

“Men with breast cancer are often left to fight the disease in silence. This silence has led to psychological and emotional distress in conjunction with illness-related stigmas.” www.oncnursingnews.com/view/looking...

oncnursingnews.com

Looking More Closely at Breast Cancer in Male Patients

Although breast cancer has historically been associated with female patients, the rates of men with breast cancer have been increasing over the past decade.

052

Reposted by Amy Beumer

Janice Cowden @janicetnbcmets.bsky.social · 18/12/2024

It’s a privilege to be part of this meaningful work! The ASCO CDK Dosing Study has the potential to reshape clinical practice for older adults w/ #metastaticbreastcancer. Thnx to PCORI for funding this impactful project. @therightdose.bsky.social @oncoalert.bsky.social #bcsm #DoseOptimization #QoL

2339

Amy Beumer @amybeumer.bsky.social · 15/12/2024

Thank you- just an other worldly view, hard to take a bad picture heh.

010

Amy Beumer @amybeumer.bsky.social · 14/12/2024

Home sweet home and an awesome sunset in flight.

2300

Reposted by Amy Beumer

Julia Maués @itsnotpink.bsky.social · 13/12/2024

To build on the progress shared at #SABCS24 for triple-positive MBC ( #PATINA), when treatments stop working, is it the HER2 or HR component driving resistance? Need a biomarker! Patients want the most mileage from every treatment! PS: Finally, +++ is being treated differently from HER2+/HR–.

1135

Reposted by Amy Beumer

Dionisia Quiroga, DO, PhD, FASCO @quirogad.bsky.social · 14/12/2024

Was great to talk to @janicetnbcmets.bsky.social about this a couple days ago —> higher doses are not always better ✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge! #bcsm #SABCS24

0114

Amy Beumer @amybeumer.bsky.social · 14/12/2024

I did not hear anyone say “grade 5 adverse event” and for that I am grateful.

010

Reposted by Amy Beumer

Prof Bogda Koczwara @bogda-koczwara.bsky.social · 13/12/2024

Hot of the press from @proteuspros - an infographic explaining the value of PROs! Note - they need to start as parr of the clinical encounter to benefit patients and society. tinyurl.com/3m594fhk

165

Reposted by Amy Beumer

Stacey Tinianov, MPH @coffeemommy.bsky.social · 14/12/2024

Spent 90 mins on the #SABCS24 stage, interjecting the advocacy perspective in "From the Trenches" yesterday. It was these voices, and so many others not pictured, that I channeled. Grateful to have them by my side literally & figuratively 💗

23310

Amy Beumer @amybeumer.bsky.social · 14/12/2024

Love when MBC, the kind of breast cancer that kills, gets 12 minutes in a 90 minute presentation on what to bring back to the clinic. We’re flying and skipping audience questions. #bcsm #SABCS24

051

Amy Beumer @amybeumer.bsky.social · 14/12/2024

There is no “good risk” only lower risk. There is no good DCIS. Need to talk about absolute risk as well. @coffeemommy.bsky.social #bcsm

0124

Amy Beumer @amybeumer.bsky.social · 14/12/2024

@coffeemommy.bsky.social giving nuance to a conversation about patient treatment on Monday morning. Patients do not live in a utopia and we are not a monolith! #bcsm #sabcs24

050

Amy Beumer @amybeumer.bsky.social · 14/12/2024

That’s true but it’s definitely a better term then deescalation which sounds like “you don’t deserve more treatment” for whatever reason

010

Amy Beumer @amybeumer.bsky.social · 13/12/2024

View from the trenches at #SABCS24 with the amazing @coffeemommy.bsky.social We need to “right size” treatment (NOT “deescalate”) with discussions on risk, benefit and impact of treatment. YES! #oncsky #bcsm

0116

Amy Beumer @amybeumer.bsky.social · 13/12/2024

Excellent work! Would love for him to join and share his thoughts here.

010

Amy Beumer @amybeumer.bsky.social · 13/12/2024

This is great! Maybe add in ET alone in first line for select patients (SONIA). Great presentation by Dr. Danso. #bcsn #SABCS24

030

Amy Beumer @amybeumer.bsky.social · 13/12/2024

One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.

042

Reposted by Amy Beumer

Kelly Shanahan @stage4kelly.bsky.social · 12/12/2024

Congratulations to DR Steffi Oesterreichs @oesterreichs on her AACR Award. She has done sooooo much for people with ILC, not just through her brilliant research, but through her embrace of and collaboration with advocates. @metavivor is so proud to have funded her! #SABCS24

1195

Reposted by Amy Beumer

Kelly Shanahan @stage4kelly.bsky.social · 12/12/2024

Dr @cittellylab.bsky.social’s conclusions on brain mets in ER+ (MICE), and once again proud that @metavivor has funded her research! #SABCS24

1103

Reposted by Amy Beumer

Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 12/12/2024

P-Verify is retrospx RWE look at OS in all 3 CDK4/6i w/Flatiron data, funded by Pfizer ▫️RWE is only way we’ll see this comparison -yet- ▫️RWE can have bias & limits -still- ▫️Reassuring to see NO DIFFERENCE in OS across 3 approved agents ▫️Needs longer F/U #SABCS24 @oncoalert.bsky.social

094

Reposted by Amy Beumer

Dr. RShatsky @dr-rshatsky.bsky.social · 11/12/2024

For those wanting to optimize their care of premenopausal HR+ early breast cancer I highly recommend watching the #SABCS24 Educational Session “Mind the Gap Breast cancer in the young.” It really reinforces the importance of ovarian suppression! Tam is not enough in so many! #bcsm #OncSky #CanSky

1227

Amy Beumer @amybeumer.bsky.social · 12/12/2024

Great discussion yesterday morning and exciting work in mTNBC! #bcsm

010

Reposted by Amy Beumer

Ahmed Elkhanany @elkhanany.bsky.social · 11/12/2024

Sobering data on 7-year IBC outcome from @mdanderson.bsky.social presented by superstar Dr. Azadeh Nasrazadani. 7-year OS % 7, 24, 50, 55 in TNBC, ER+ HER2-, ER- HER2+ and ER+HER2+. CDK4/6i benefit low compared with historic cohorts. @naborala.bsky.social we need better Rx. #SABCS24 #bcsm

2105

Reposted by Amy Beumer

Elisa Agostinetto @elisaagostinetto.bsky.social · 11/12/2024

At #SABCS24 LBA session - @dradityabardia on Efficacy and Safety of T-DXd by Pace of Disease Progression on Prior Endocrine-Based Therapy in DESTINY-Breast06 T-DXd ⬆️PFS regardless of time to progression on 1st line CDK4/6i+ET or type of endocrine resistance @oncoalert.bsky.social

0139

Reposted by Amy Beumer

Tatiana Prowell, MD @tmprowell.bsky.social · 10/12/2024

#SABCS24 #bcsm #OncSky We need to ask all patients on endocrine therapy for #breastcancer about vaginal dryness & sexual dysfunction. Here’s a useful stepwise approach to managing these issues from @JenniShengMD. #MedSky @oncoalert.bsky.social

22915

Reposted by Amy Beumer

Dr. RShatsky @dr-rshatsky.bsky.social · 11/12/2024

Take Away from Keynote 522 biomarker analysis. We still don’t know why people benefit from pembro. Even people we expect not to benefit (LAR) surprisingly do… . Unfortunately this biomarker analysis did not help us narrow down the groups that don’t need it. #bcsm #SABCS24

2115

Reposted by Amy Beumer

Kelly Shanahan @stage4kelly.bsky.social · 10/12/2024

So happy to support my friend @itsnotpink.bsky.social as she brings the @The_Right_Dose patient expert perspective on dose optimization to #SABCS24

0145

Amy Beumer @amybeumer.bsky.social · 10/12/2024

This was a super informative talk including what works and what to avoid. Need more cannabis research!

042

Reposted by Amy Beumer

Kelly Shanahan @stage4kelly.bsky.social · 10/12/2024

What are some ways to get to the right dose? Sequential trials, more than 2 arms, re-randomization are potential solutions for dose optimization. @The_Right_Dose #SABCS24

083

Amy Beumer @amybeumer.bsky.social · 10/12/2024

Thank you for this work @drdonsdizon.bsky.social and all authors. A clear lack of evidence for transgender individuals with cancer that needs to be remedied AND some great recs for physicians that in many cases could apply to advocacy as well. Well worth a read. #oncsky #bcsm

092

Amy Beumer @amybeumer.bsky.social · 09/12/2024

Tried to click through and it gave me a 404 does not exist error. Could be me, but wanted to make sure.

210